(Total Views: 650)
Posted On: 06/10/2024 9:45:44 PM
Post# of 154624
Dr. Jay's knows. Fr9m the 3/5 webcast:
“I would also like to note the growing body of evidence implicating the role of inflammation, and specifically CCR-five in the pathogenesis of Alzheimer's disease. This is obviously an area of enormous and urgent unmet needs. And given the [well tolerated] safety profile of LeronLimab to date, together with data from a recent preclinical study suggesting that blocking CCR5 in mice can rescue memory deficits. I believe a pilot study in patients with Alzheimer's disease is now justified.”
“I would also like to note the growing body of evidence implicating the role of inflammation, and specifically CCR-five in the pathogenesis of Alzheimer's disease. This is obviously an area of enormous and urgent unmet needs. And given the [well tolerated] safety profile of LeronLimab to date, together with data from a recent preclinical study suggesting that blocking CCR5 in mice can rescue memory deficits. I believe a pilot study in patients with Alzheimer's disease is now justified.”
(3)
(0)
